Patient Advocacy and Medical Professional Coalition Applauds FDA Warning Letters but Urges Greater Enforcement
Posted on: Thursday, 10 August 2006, 18:00 CDT
FAIRFAX, Va., Aug. 10 /PRNewswire/ -- The Consumer Health Alliance for Safe Medication (CHASM), a national working group of patient advocates and medical professional associations, welcomes the Food and Drug Administration (FDA) warnings to three national pharmacies to stop manufacturing unlawful nebulizer medication.
The manufacturers who received warning letters include Rotech Healthcare, Inc., Reliant Pharmacy Services, and CCS Medical. FDA states that the products in question are not approved for safety or efficacy and typically are not sterile.
"While we commend the FDA for sending out these warning letters, we need the agency to go one step further and force these companies to notify patients who are in receipt of unlawful and potentially unsafe medications," said Nancy Sander, president and founder of Allergy & Asthma Network Mothers of Asthmatics, a CHASM alliance member.
"Millions of doses have been manufactured and distributed, but patients and prescribers alike are often unaware that their prescriptions for FDA- approved medications were substituted with unapproved, unlawful medications made by Rotech, Reliant and CCS Medical."
To learn more about whether your medications may be unlawfully mass manufactured:
http://www.breatherville.org/pdf/pu_fakes_frauds.pdf Link to FDA Press Release: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01428.html About CHASM
AANMA convened the Consumer Health Alliance for Safe Medication (CHASM), a working group of patient and professional healthcare associations, to ensure patients with respiratory conditions have access to safe and effective medications and are protected from products that may pose unwarranted risks. These respiratory conditions include asthma, cystic fibrosis, pneumonia and chronic obstructive pulmonary diseases (COPD).
Allergy & Asthma Network Mothers of Asthmatics (AANMA) American Academy of Allergy Asthma and Immunology (AAAAI) American College of Allergy Asthma and Immunology (ACAAI) American Latex Allergy Association (A.L.E.R.T., Inc.) American Partnership For Eosinophilic Disorders (APFED) American Association for Respiratory Care (AARC) Association of Asthma Educators (AAE) Asthma and Allergy Foundation of America (AAFA) National Association for Medical Direction of Respiratory Care (NAMDRC) American Academy of Nurse Practitioners (AANP) National Emphysema and COPD Association (NECA) COPD-ALERT
Consumer Health Alliance for Safe Medication
CONTACT: Desiree Diez of the Consumer Health Alliance for SafeMedication, +1-703-641-9595, ext. 114
Source: PRNewswire
Related Articles
- Alliance for Digital Equality, Connected Nation and Communications Workers of America (CWA) Form National Partnership in Response to Call to Action Cited in the American Recovery and Reinvestment Act of 2009 (ARRA)
- ConforMIS, Inc. Is Named the Winner of the 2008 North American Frost & Sullivan Award for Medical Device Healthcare Innovation
- London Luxury Receives Asthma & Allergy Friendly(TM) Certification for Several of Its Bedding Products
- Montecito Medical Acquires Medical Office Building
- BioPharmetics (BPMT) Signs Strategic Alliance Agreement With Medical Cost Management, Inc. (MCM)
- BioPharmetics (BPMT) Signs Strategic Alliance With Universal Medical Distributors, Inc. (UMDI)
- China, In Terms of Both Its Healthcare System and Medical Device Market, is a Nation of Contradiction
- FDA Deputy Commissioner to Announce New FDA Initiatives to Disseminate Medical Information at NPC, Sept. 28
- La. Expert: Allergies a Problem Year-Round Head of Asthma, Allergy Group Urges Continuous Monitoring, Treatment to Fight Disease
- Consumer Health Alliance for Safe Medication Petitions FDA to Better Protect Patients
 |
 |
User Comments (0)
RSS Feeds